This inventor holds 3 USPTO granted patents. Top assignee: Arius Research, Inc.. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Luis A G Da Cruz: Innovator in Cancer Treatment
Introduction
Luis A G Da Cruz is a prominent inventor based in Toronto, Canada. He has made significant contributions to the field of cancer treatment through his innovative research and inventions. With a total of 3 patents, his work focuses on the diagnosis and treatment of cancerous diseases.
Latest Patents
One of his latest patents is titled "Cytotoxicity mediation of cells evidencing surface expression of CD63." This invention relates to the diagnosis and treatment of cancerous diseases, particularly the mediation of cytotoxicity of tumor cells. It emphasizes the use of cancerous disease modifying antibodies (CDMAB), optionally in combination with one or more chemotherapeutic agents, as a means for initiating the cytotoxic response. The invention further includes binding assays that utilize the CDMABs developed by Da Cruz.
Career Highlights
Luis A G Da Cruz is associated with Arius Research, Inc., where he continues to advance his research in cancer treatment. His work has garnered attention for its potential to improve therapeutic outcomes for patients suffering from cancer.
Collaborations
Some of his notable coworkers include David S F Young and Helen P Findlay, who contribute to the collaborative efforts at Arius Research, Inc.
Conclusion
Luis A G Da Cruz is a dedicated inventor whose work in cancer treatment is paving the way for innovative therapeutic strategies. His contributions are vital in the ongoing fight against cancer, and his patents reflect his commitment to improving patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile